The Role of Periostin in the Occurrence and Progression of Eosinophilic Chronic Sinusitis with Nasal Polyps
Affiliations
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a highly heterogeneous disease with different host defence responses. However, whether periostin and vascular endothelial growth factor (VEGF) are similarly impaired in patients with eosinophilic CRSwNP (ENP) and those with non-eosinophilic CRSwNP (nENP) remains unclear. We sought to evaluate the expression and possible modulation of periostin and VEGF, regulated on activation normal T expressed and secreted (RANTES) and eotaxin-2 in the polyp tissues from 30 patients with ENP and from 36 patients with nENP and in middle turbinate tissues from 12 control subjects. We found that ENP tissues exhibited a significantly increased expression of periostin and VEGF compared with tissues from patients with nENP and control subjects (P < 0.05, respectively). Accordingly, the expression of VEGF, RANTES, and eotaxin-2 in ENP fibroblasts was significantly up-regulated after stimulation with up-regulated periostin in vitro, but the expression of VEGF and RANTES was significantly inhibited by stimulation with down-regulated periostin. Our findings suggest that periostin might play an important role in the occurrence and progression of ENP and might be a potential therapeutic target.
Zhang J, Cao Y, Chen K, Hu X, Zhou C, Li L Asia Pac Allergy. 2024; 14(3):97-102.
PMID: 39220569 PMC: 11365693. DOI: 10.5415/apallergy.0000000000000148.
Kim J, Hegener K, Hagedorn C, Weidinger D, Jamal Jameel K, Seuthe I BMC Mol Cell Biol. 2023; 24(1):31.
PMID: 37817076 PMC: 10566096. DOI: 10.1186/s12860-023-00493-2.
Zhang J, Cheng S, Xie S, Xie Z, Zhang H, Wang F Braz J Otorhinolaryngol. 2023; 89(2):321-328.
PMID: 36754676 PMC: 10071535. DOI: 10.1016/j.bjorl.2022.11.004.
Roles of Exosomes in Chronic Rhinosinusitis: A Systematic Review.
Dzaman K, Czerwaty K Int J Mol Sci. 2022; 23(19).
PMID: 36232588 PMC: 9570170. DOI: 10.3390/ijms231911284.
Zhang Y, Zhu K, Chen J, Xia C, Yu C, Gao T Mediators Inflamm. 2022; 2022:9155080.
PMID: 35633657 PMC: 9135518. DOI: 10.1155/2022/9155080.